According to the research report titled ‘Global Biologics Safety Testing Market - Analysis By Product, Test, Application, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)’, available with MarketStudyReport, global biologics safety testing market was worth USD 3463.90 million in 2020 and is anticipated to showcase lucrative growth trends between 2021 and 2026.
 

Expanding biotechnology & pharmaceutical sector due to rising government support, increasing investments for life sciences research & development, and growing number of new drug launches are the major factors driving the global biologics safety testing market growth.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3578559/
 

Growing prevalence & rising economic burden of chronic diseases, along with legislative assistance for advancement in biologics are further favoring the market outlook. Moreover, increasing competition among the industry behemoths has led to introduction of some advanced drugs, thereby adding traction to the overall market size.
 

On the downside, stricter government regulations for endorsement of biologics, along with high costs associated with the medication are likely to act as bottlenecks for the market progress over the projected timeline.
 

Based on product type, the global biologics safety testing industry is segmented into services, high kits & reagents, and instruments. The report cites that high kits & reagents segment held a considerable industry share in the recent past, owing to repeated purchase of kits and reagents, along with rising adoption of kit-based testing.
 

Speaking of the application range, the marketplace is divided into vaccine & therapeutics, gene therapy, and blood & blood-based products including others. On the basis of tests, the business space is categorized into bioburden tests, sterility tests, adventitious agent detection tests, and endotoxin tests among others.
 

On the regional front, North America, Asia Pacific, and Europe are considered to be the major contributors towards the overall valuation of the industry.
 

Experts cite that North America held a significant market share in 2020 and is slated to record considerable growth over the estimated timeline, owing to increasing research & development in life sciences, expanding pharmaceutical sector, along with growing investments in biotechnology.
 

Major players profiled in worldwide biologics safety testing industry are Eurofins Scientific, Maravai Life Sciences Inc., Charles River Laboratories International Inc., Samsung Biologics, Thermo Fisher Scientific, The Merck Group, The Sartorius Group, WuXi AppTec, SGS S.A., and Lonza Group AG.